|
Vtv Therapeutics Inc (NASDAQ: VTVT) |
|
Vtv Therapeutics Inc
VTVT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Vtv Therapeutics Inc growth rates, revenue grew
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Vtv Therapeutics Inc net loss decreased from $-4 millions, to $-4 millions in IV. Quarter 2024,
• More on VTVT's Growth
|
|
Vtv Therapeutics Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.7 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 126.11.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on VTVT's Valuation
|
|
|
|
|
Vtv Therapeutics Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.7 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 126.11.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
Vtv Therapeutics Inc Price to Book Ratio is at 8.97 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01
• More on VTVT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com